Longevity Genes in Founder Populations

该项目的总体目标是通过研究两个独特的创始人群体（旧秩序阿米什人和德系犹太人）中的“最年长的老人”及其后代，定位人类长寿的染色体位点（最终是基因）。这些群体是这些研究的理想群体，因为它们是遗传上相对同质的创始人群体，并且以前一直是成功鉴定疾病基因的基础。 该提案汇集了老年医学，分子遗传学，流行病学和统计遗传学领域强大的多学科研究人员团队，他们具有良好的合作记录，并与这些封闭人群密切合作。 首先，我们将招募Amish和Ashkenazi先证者（年龄大于95岁）及其家庭成员。 第二，我们将进行一个全基因组的长寿保证基因的多重阿米什人家系基因分型391多态性短串联重复序列（STR）标记间隔约10厘米的间隔，并进行“affecteds”只有连锁分析。 第三，我们将对阿米什人和德系犹太人研究对象进行详细的表型表征。 我们将通过比较先证者的后代（病例）和后代的配偶（对照）之间的平均性状差异来确定相关的与年龄相关的中间数量性状。 一旦确定了相关的衰老相关性状，我们将在2000多名已被招募和基因分型的阿米什人受试者中使用方差分量法进行全基因组搜索，以寻找控制这些数量性状的基因。 最后，为了加强连锁和改善连锁信号的定位，我们将在阿米什人中以0.5 - 1 cM的间隔键入额外的标记，并进行后续的连锁分析和关联分析，包括单倍型共享分析。 这些相同的标记将在德系犹太人中进行基因分型，以可能确认该人群中的关联，并进一步帮助缩小连锁/关联的区域。 作为这些研究的结果，我们将（1）表征两个独特的家族收藏丰富的长寿和长寿相关的表型，其中遗传和非遗传可以研究（环境）对寿命的影响;（2）通过定位克隆和定位候选基因方法鉴定可能含有长寿保证基因的特定染色体区域，（3）建立了一个后代队列，将对其进行纵向研究，以进一步确定相关的中间长寿表型，并将长寿基因的遗传与其长寿表型相关联。 长寿保障基因的发现将为衰老的分子基础以及衰老相关疾病的预防和治疗提供重要的见解。这些进步将对美国老年人的健康和生活质量产生重大影响。

The overall objective of this project is to localize chromosomal loci (and ultimately genes) for longevity in humans by studying the "oldest old' and their offspring in two unique founder populations, the Old Order Amish and Ashkenazi Jews. These populations are ideal for these studies because they are relatively genetically homogeneous founder populations, and previously have been the basis of successful identification of disease genes. This proposal brings together a strong multidisciplinary team of researchers in the areas of geriatrics, molecular genetics, epidemiology, and statistical genetics who have a proven track record of collaboration and who work closely with these closed populations. First, we will recruit Amish and Ashkenazi probands (age greater than 95 years) and their family members. Second, we will perform a genome-wide search for longevity assurance genes in multiplex Amish pedigrees by genotyping 391 polymorphic short tandem repeat (STR) markers spaced at approximately 10 cM intervals and performing 'affecteds' only linkage analysis. Third, we will perform detailed phenotypic characterization of Amish and Ashkenazi study subjects. We will identify relevant aging-related intermediate quantitative traits by comparing mean trait differences between the probands' offspring (cases) and the offsprings' spouses (controls). Once relevant aging-related traits are identified, we will perform a genome wide search for genes controlling these quantitative traits using variance components methods in over 2000 Amish subjects who have already been recruited and genotyped. Finally, to strengthen linkages and improve localization of linkage signals, we will type additional markers at 0.5 - 1 cM intervals in the Amish, and perform follow-up linkage analysis and association analyses, including haplotype sharing analysis. These same markers will be genotyped in Ashkenazi Jews to possibly confirm associations in this population and also to help narrow regions of linkage/association further. As a result of these studies, we will have (1) characterized two unique family collections enriched for longevity and longevity-related phenotypes in which genetic and nongenetic (environmental) influences on longevity may be studied; (2) identified specific chromosomal regions that are likely to harbor longevity assurance genes for subsequent identification through positional cloning and positional candidate gene approaches, and (3) established an offspring cohort that will be studied longitudinally in order to further define the relevant intermediate longevity phenotypes, and to correlate inheritance of longevity genes to their longevity phenotypes. Discovery of longevity assurance genes will provide critical insights into the molecular basis of aging as well as new strategies for prevention and therapy of aging-related diseases. These advances will impact substantially on the health and quality of life of older Americans.